Home Up Next

 

 

 

 

 

Cardiology


 

 

Bylined news reports distributed on Reuters Health wire service [FR, writer]:

  • Smoking increases risk of diabetic nephropathy despite ACE inhibition, 1-28-2003.

  • Nesiritide safer than dobutamine for treatment of decompensated CHF, 1-13-2003.

  • Addition of abciximab to reteplase benefits MI patients with prior bypass graft, 1-9-2003.

  • New data fuel debate about role of fibrinolytic system in vascular remodeling, 1-8-2003.

  • Very elderly patients appear to benefit most from statin therapy for CAD, 11-26-2002.

  • Creatine kinase-MB can rule out perioperative MI after bypass surgery, 11-22-2002.

  • Ritonavir damage to endothelial cells may explain its vascular effects, 10-25-2002.

  • Benefit persists after nonsurgical septal reduction in cardiac hypertrophy, 10-24-2002.

  • Antichlamydial effect of aspirin might explain its cardioprotective activity, 8-1-2002.

  • LDL-apheresis can reduce plaque in patients with familial hypercholesterolemia, 7-30-2002.

  • Protease inhibitor use linked to changes in cardiac structure and function, 7-24-2002.

  • Prehospital fibrinolysis can be worthwhile even in urban areas, 7-23-2002.

  • Microalbuminuria, type 2 diabetes, CVD develop together over decades, 6-21-2002.

  • Cardiac autonomic function better with combination HRT than estrogen alone, 6-19-2002.

  • Hyperhomocystinemia impairs vascular function in rats, 6-13-2002.

  • Animal model of spontaneous plaque rupture developed, 6-5-2002.

  • X-Sizer thrombectomy effective for patients with acute coronary syndromes, 5-15-2002.

  • Heart attack risk jumps as aspirin sensitivity lost, 3-25-2002.

  • Short-term outcome of acute CHF better with nesiritide than dobutamine, 3-21-2002.

  • Endogenous testosterone may protect postmenopausal women from CVD, 3-14-2002.

  • Even mild stress can raise blood pressure, 2-4-2002.

  • Weight loss cuts level of heart-risk-linked protein, 2-4-2002.

  • Fever after bypass linked to mental difficulties, 1-31-2002.

  • Neurotensin analog produces cerebral hypothermia in rats after cardiac arrest, 1-17-2002.

  • New blood test for heart disease proposed, 1-17-2002.

  • More aggressive BP lowering urged for adults with renal insufficiency, 1-7-2002.

  • Pravastatin reduces stroke risk after MI even if lipid levels not high, 1-25-1999.

  • Orlistat plus diet produces modest weight loss, improves CVD risk factors, 1-20-1999.

  • Imaging test predicts heart attack, stroke risk, 1-6-1999.

  • Vesnarinone improves QOL but increases mortality in severe heart failure, 12-17-1998.

  • Estrogen replacement reduces plasma viscosity in older women, 12-11-1998.

  • Angiopoietins might have role in therapeutic angiogenesis, 10-16-1998.

  • No added cardiovascular disease risk from newer oral contraceptives, 10-9-1998.

  • Cyclosporin may prevent heart enlargement, 9-10-1998.

  • Estrogen replacement therapy benefits postmenopausal women with CHD, 8-27-1998.

  • HRT does not reduce CVD risk in heart patients, 8-18-1998.

  • New drug cuts heart risk in unstable angina, 8-12-1998.

  • Cardiovascular response to stress influences atherosclerosis risk, 8-7-1998.

  • Oral diuresis suitable for many edematous patients with CHF, 7-13-1998.

  • Atherosclerosis can begin in childhood, 6-3-1998.

  • No link between dexfenfluramine, pulmonary hypertension in rats, 5-13-1998.

  • Redefinition of “normal” triglyceride levels indicated, 5-1-1998.

  • New type of antihypertensive agent shows promise in rats, 4-16-1998.

  • Clot dissolver treats blocked leg arteries, 4-15-1998.

  • Many stroke survivors do well, 4-2-1998.

  • Heart attack treatment questioned, 3-31-1998.

  • Low vitamin C associated with heart attacks, 3-31-1998.

Home • Bev Caley • Faith Reidenbach • Services • What We've Written • Client Experience • What Our Clients Say

 

Send mail to Bev@caleyreidenbach.com with questions or comments about this web site.
Last modified: 08/09/07